Considering that CD9/CD81 DKO mice develop not only emphysema but also some of the extra-pulmonary diseases seen in COPD patients, such as body weight loss and osteoporosis, we regard these DKO mice as a novel model for human COPD32. This evidence concerns the gene CD9 and chronic obstructive pulmonary disease.